Tubulin hyperacetylation is adaptive in cardiac proteotoxicity by promoting autophagy

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 48, 2014, Pages E5178-E5186

  McLendon, Patrick M ^a   Ferguson, Bradley S ^b   Osinska, Hanna ^a   Shenuarin Bhuiyan, Md ^a   James, Jeanne ^a   McKinsey, Timothy A ^b   Robbins, Jeffrey ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CRYSTALLIN; HDAC6 PROTEIN, MOUSE; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID; TUBULIN; VORINOSTAT;

ACETYLATION; ADAPTATION; ANIMAL; AUTOPHAGY; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; ELECTRON MICROSCOPY; GENETICS; HEART; HEART MUSCLE; HEART MUSCLE CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; METABOLISM; MUTATION; NEWBORN; PHYSIOLOGY; PRIMARY CELL CULTURE; SPRAGUE DAWLEY RAT; TRANSGENIC MOUSE; ULTRASTRUCTURE;

ACETYLATION; ADAPTATION, PHYSIOLOGICAL; ALPHA-CRYSTALLIN B CHAIN; ANIMALS; ANIMALS, NEWBORN; AUTOPHAGY; CELLS, CULTURED; HEART; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HYDROXAMIC ACIDS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MICE, TRANSGENIC; MICROSCOPY, ELECTRON; MUTATION; MYOCARDIUM; MYOCYTES, CARDIAC; PRIMARY CELL CULTURE; RATS, SPRAGUE-DAWLEY; TUBULIN;

EID: 84914145409     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1415589111     Document Type: Article

References (62)

1. Willis MS, Patterson C (2013) Proteotoxicity and cardiac dysfunction-Alzheimer's disease of the heart? N Engl J Med 368(5):455-464.
2. Senyo SE, et al. (2013) Mammalian heart renewal by pre-existing cardiomyocytes. Nature 493(7432):433-436.
3. Porrello ER, et al. (2011) Transient regenerative potential of the neonatal mouse heart. Science 331(6020):1078-1080.
4. Hill JA, Olson EN (2008) Cardiac plasticity. N Engl J Med 358(13):1370-1380.
5. Zhu H, et al. (2007) Cardiac autophagy is a maladaptive response to hemodynamic stress. J Clin Invest 117(7):1782-1793.
6. Tannous P, et al. (2008) Intracellular protein aggregation is a proximal trigger of cardiomyocyte autophagy. Circulation 117(24):3070-3078.
7. Vicart P, et al. (1998) A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet 20(1):92-95.
8. Wang X, et al. (2003) AlphaB-crystallin modulates protein aggregation of abnormal desmin. Circ Res 93(10):998-1005.
9. Wang X, et al. (2001) Expression of R120G-alphaB-crystallin causes aberrant desmin and alphaB-crystallin aggregation and cardiomyopathy in mice. Circ Res 89(1):84-91.
10. McLendon PM, Robbins J (2011) Desmin-related cardiomyopathy: An unfolding story. Am J Physiol Heart Circ Physiol 301(4):H1220-H1228.
11. Goldfarb LG, Dalakas MC (2009) Tragedy in a heartbeat: Malfunctioning desmin causes skeletal and cardiac muscle disease. J Clin Invest 119(7):1806-1813.
12. Capetanaki Y (2002) Desmin cytoskeleton: A potential regulator of muscle mitochondrial behavior and function. Trends Cardiovasc Med 12(8):339-348.
13. Bova MP, et al. (1999) Mutation R120G in alphaB-crystallin, which is linked to a desmin-related myopathy, results in an irregular structure and defective chaperone-like function. Proc Natl Acad Sci USA 96(11):6137-6142.
14. Maloyan A, et al. (2005) Mitochondrial dysfunction and apoptosis underlie the pathogenic process in a-B-crystallin desmin-related cardiomyopathy. Circulation 112(22):3451-3461.
15. Maloyan A, Sayegh J, Osinska H, Chua BHL, Robbins J (2010) Manipulation of death pathways in desmin-related cardiomyopathy. Circ Res 106(9):1524-1532.
16. Sanbe A, et al. (2004) Desmin-related cardiomyopathy in transgenic mice: A cardiac amyloidosis. Proc Natl Acad Sci USA 101(27):10132-10136.
17. Pattison JS, Osinska H, Robbins J (2011) Atg7 induces basal autophagy and rescues autophagic deficiency in CryABR120G cardiomyocytes. Circ Res 109(2):151-160.
18. Chen Q, et al. (2005) Intrasarcoplasmic amyloidosis impairs proteolytic function of proteasomes in cardiomyocytes by compromising substrate uptake. Circ Res 97(10): 1018-1026.
19. Wang X, Osinska H, Gerdes AM, Robbins J (2002) Desmin filaments and cardiac disease: Establishing causality. J Card Fail 8(6, Suppl):S287-S292.
20. Iwata A, Riley BE, Johnston JA, Kopito RR (2005) HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin. J Biol Chem 280(48): 40282-40292.
21. Geeraert C, et al. (2010) Starvation-induced hyperacetylation of tubulin is required for the stimulation of autophagy by nutrient deprivation. J Biol Chem 285(31): 24184-24194.
22. Mackeh R, Perdiz D, Lorin S, Codogno P, Poüs C (2013) Autophagy and microtubules: New story, old players. J Cell Sci 126(Pt 5):1071-1080.
23. Kong Y, et al. (2006) Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation 113(22):2579-2588.
24. Xie M, et al. (2014) Histone deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy. Circulation 129(10):1139-1151.
25. Granger A, et al. (2008) Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice. FASEB J 22(10):3549-3560.
26. Cavasin MA, et al. (2012) Selective class I histone deacetylase inhibition suppresses hypoxia-induced cardiopulmonary remodeling through an antiproliferative mechanism. Circ Res 110(5):739-748.
27. McConkey DJ, White M, Yan W (2012) HDAC inhibitor modulation of proteotoxicity as a therapeutic approach in cancer. Adv Cancer Res 116:131-163.
28. Haberland M, Montgomery RL, Olson EN (2009) The many roles of histone deacety-lases in development and physiology: Implications for disease and therapy. Nat Rev Genet 10(1):32-42.
29. Zhao TC, Cheng G, Zhang LX, Tseng YT, Padbury JF (2007) Inhibition of histone de-acetylases triggers pharmacologic preconditioning effects against myocardial ische-mic injury. Cardiovasc Res 76(3):473-481.
30. Cao DJ, et al. (2011) Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy. Proc Natl Acad Sci USA 108(10):4123-4128.
31. d'Ydewalle C, Bogaert E, Van Den Bosch L (2012) HDAC6 at the intersection of neu-roprotection and neurodegeneration. Traffic 13(6):771-779.
32. Kawaguchi Y, et al. (2003) The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 115(6):727-738.
33. Pandey UB, et al. (2007) HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447(7146):859-863.
34. Li Y, Shin D, Kwon SH (2013) Histone deacetylase 6 plays a role as a distinct regulator of diverse cellular processes. FEBS J 280(3):775-793.
35. Kraft C, Peter M, Hofmann K (2010) Selective autophagy: Ubiquitin-mediated recognition and beyond. Nat Cell Biol 12(9):836-841.
36. Olzmann JA, et al. (2007) Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6. J Cell Biol 178(6):1025-1038.
37. Lemon DD, et al. (2011) Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension. J Mol Cell Cardiol 51(1):41-50.
38. Demos-Davies KM, et al. (2014) HDAC6 contributes to pathological responses of heart and skeletal muscle to chronic angiotensin-II signaling. Am J Physiol Heart Circ Physiol 307(2):H252-H258.
39. Xie M, Hill JA (2013) HDAC-dependent ventricular remodeling. Trends Cardiovasc Med 23(6):229-235.
40. Thomas EA, et al. (2008) The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice. Proc Natl Acad Sci USA 105(40):15564-15569.
41. Steffan JS, et al. (2001) Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413(6857):739-743.
42. Sanbe A, et al. (2009) Protective effect of geranylgeranylacetone via enhancement of HSPB8 induction in desmin-related cardiomyopathy. PLoS ONE 4(4):e5351.
43. Sanbe A, et al. (2005) Reversal of amyloid-induced heart disease in desmin-related cardiomyopathy. Proc Natl Acad Sci USA 102(38):13592-13597.
44. Hockly E, et al. (2003) Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc Natl Acad Sci USA 100(4):2041-2046.
45. Bhuiyan MS, et al. (2013) Enhanced autophagy ameliorates cardiac proteinopathy. J Clin Invest 123(12):5284-5297.
46. Su H, Wang X (2011) p62 Stages an interplay between the ubiquitin-proteasome system and autophagy in the heart of defense against proteotoxic stress. Trends Cardiovasc Med 21(8):224-228.
47. He C, et al. (2012) Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis. Nature 481(7382):511-515.
48. Maloyan A, Gulick J, Glabe CG, Kayed R, Robbins J (2007) Exercise reverses preamyloid oligomer and prolongs survival in alphaB-crystallin-based desmin-related cardiomy-opathy. Proc Natl Acad Sci USA 104(14):5995-6000.
49. Kopito RR (2000) Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 10(12):524-530.
50. Rubinsztein DC (2006) The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443(7113):780-786.
51. Aguzzi A, O'Connor T (2010) Protein aggregation diseases: Pathogenicity and therapeutic perspectives. Nat Rev Drug Discov 9(3):237-248.
52. Hull RL, Westermark GT, Westermark P, Kahn SE (2004) Islet amyloid: A critical entity in the pathogenesis of type 2 diabetes. J Clin Endocrinol Metab 89(8):3629-3643.
53. Wang X, et al. (2001) Mouse model of desmin-related cardiomyopathy. Circulation 103(19):2402-2407.
54. Bulteau A-L, et al. (2001) Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. J Biol Chem 276(32):30057-30063.
55. Sarikas A, et al. (2005) Impairment of the ubiquitin-proteasome system by truncated cardiac myosin binding protein C mutants. Cardiovasc Res 66(1):33-44.
56. Yi J, et al. (2013) Sodium valproate alleviates neurodegeneration in SCA3/MJD via suppressing apoptosis and rescuing the hypoacetylation levels of histone H3 and H4. PLoS ONE 8(1):e54792.
57. Zhang X, et al. (2007) HDAC6 modulates cell motility by altering the acetylation level of cortactin. Mol Cell 27(2):197-213.
58. Wang L, de Zoeten EF, Greene MI, Hancock WW (2009) Immunomodulatory effects of deacetylase inhibitors: Therapeutic targeting of FOXP3+ regulatory T cells. Nat Rev Drug Discov 8(12):969-981.
59. Brochier C, et al. (2013) Specific acetylation of p53 by HDAC inhibition prevents DNA damage-induced apoptosis in neurons. J Neurosci 33(20):8621-8632.
60. Winter L, et al. (2014) Chemical chaperone ameliorates pathological protein aggregation in plectin-deficient muscle. J Clin Invest 124(3):1144-1157.
61. Lee JY, et al. (2010) HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy. EMBO J 29(5):969-980.
62. Committee for the Update of the Guide for the Care and Use of Laboratory Animals (2011) Guide for the Care and Use of Laboratory Animals (National Academies Press, Washington, DC).